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Abstract
Background:  Crohn's disease (CD) and ulcerative colitis (UC) are the most frequent
inflammatory bowel disorders (IBD). IBD cause a significant burden to society due to extensive
health care utilization from the first clinical symptoms until diagnosis and thereafter due to direct
and indirect costs. Besides the socio-economic impact of CD and UC, gastrointestinal and
extraintestinal symptoms affect quality of life, but there is remarkably little data about the quality
of treatment as assessed by patient satisfaction, quality of life and adherence to guidelines. Thus the
aim of this study was to identify variables that influence quality of treatment and quality of life as
well as patient satisfaction.
Methods:  The Essener Zirkel Study was a cross sectional study of 86 IBD-patients with a
confirmed diagnosis of CD or UC. They were recruited at primary, secondary and tertiary care
settings. Quality of treatment, quality of life and patient satisfaction were evaluated. Consulting
behaviour and number of examinations, duration of disease and variables regarding adherence to
guidelines were evaluated, too.
Results: 59 (69%) patients had CD and 27 had UC (31%). 19% spent more than four years until
the suspected diagnosis of IBD was confirmed and visited more than five physicians. All patients
showed a significantly reduced quality of life compared to the 1998 German normative population.
In spite of being under medical treatment, nearly half of the patients suffered from strong quality
of life restricting symptoms. Over all, 35% described their treatment as moderate or bad. Patients
who consulted psychotherapists and non-medical practitioners suffered significantly less from
depression.
Conclusion:  Besides structural deficiencies due to the health care policy, we revealed the
adherence to guidelines to be a problem area. Our findings support the assumption, that providing
better health care and especially maintaining constant patient-physician communication improves
patient satisfaction.
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Background
Crohn's disease (CD) and ulcerative colitis (UC) are the
most frequent inflammatory bowel disorders (IBD) with
a prevalence of approximately one in 500 [1]. In some
instances, these diseases have overlapping clinical and
pathological features, such as fever and submucosal
edema [2]. A subgroup of patients was shown to have a
slight increase in mortality [3], however, the primary aim
of treatment is to induce and maintain remission as well
as to prevent relapse. Main treatment options for manag-
ing IBD include enteral feeding, steroids to reduce inflam-
mation, immunosuppressive agents and surgery in
selected cases. IBD produces a range of gastrointestinal
and extraintestinal symptoms, which greatly influence the
patient's quality of life [4]. Despite significant therapeutic
advances in recent years, patients require lifelong treat-
ment in most cases. IBD is a chronic disease with early
onset before 30 years of age and without medical cure. For
these reasons, the burden of CD and UC is substantial on
the health care system [5,6]. The chronic character of both
CD and UC is characterized by periods of active disease
and remission, and active periods of disease require long-
lasting drug treatment and sometimes surgeries [7].
A wide net of hospitals and physicians is established in
Germany. Medical facilities are appropriately equipped
and the statutory health insurance system provides nearly
full coverage for many medical treatments and medica-
tion. Independent of social status, nearly everybody in
Germany has access to this system. Most people see a gen-
eral practitioner at the first sign of health problems and
they are free to see the general practitioner of their choice.
Thus, general practitioners are often the first point of con-
tact for patients. If necessary, the general practitioner
refers patients to a specialist or a clinic. All hospitals in
Germany, except for private clinics, offer services for
insured patients.
The Essener Zirkel project aims to improve the quality of
care at the interface between general practitioner, special-
ist and clinic. Focus groups discussed experiences and
concerns and it became clear, that the patient's needs
must be met. The quality of treatment has been increas-
ingly recognized as an important aspect. It is particularly
important in diseases such as UC and CD [8]. However,
there is only limited information about it. Research has
widely focussed on the pathophysiology and manage-
ment of the diseases. Thus, the aim of the study was to
identify factors that influence quality of care and patient
satisfaction. The primary target variables were time
between initial symptoms and diagnosis, information
and coordination and symptom intensity. Furthermore,
we evaluated guideline adherence for medical treatment
as well as for number and type of examinations before
and after diagnosis.
Methods
The Essener Zirkel study was a cross sectional study in the
city of Essen in the Ruhr area of Germany. It was realized
within the framework of the Essener Zirkel project that
aims to improve the quality of care of IBD. The city of
Essen has approximately 585.000 inhabitants and ranges
at sixth place among major German cities. Data was col-
lected in 5 practices of general medicine, at 3 specialised
gastroenterologists and in 3 tertiary care centres. We first
identified hospitals specializing in IBD. All of them (N =
4) were then approached for recruitment. We assigned
gastroenterologists (N = 15) and general practitioners (N
= 34) who treat IBD-patients and divided them into two
groups each according to the north-south divide in social
class inequalities. Due to feasibility 50% of gastroenterol-
ogists and general practitioners (25% within each group)
were then randomized using computer generated random
numbers. Physicians were invited to participate in the
study and to invite all presenting patients with a con-
firmed diagnosis of CD or UC during the recruiting
period. Study participants gave written informed consent.
Patients had to be at between 18 and 75 years old to be
included into this study. People with carcinoma, eating
disorder, cardiovascular, endocrine or immunologic dis-
eases and psychiatric diseases as well as pregnant women
were excluded according to the study protocol.
Variables concerning quality of treatment and quality of
life were evaluated using a standardized questionnaire.
Clinical parameters were registered from all patients.
Patient records were available if necessary. The Short Form
Health Survey (SF-36) to assess Health Related Quality of
Life (HRQOL) and the Hospital Anxiety and Depression
Scale (HADS) to assess anxiety and depression were used
[9-11]. Symptom intensity (SI) was assessed using a visual
analogue scale (ranging from 1 to 9) [12]. Consulting
behaviour and the number of examinations were evalu-
ated using a questionnaire about consultation frequencies
and examinations before and after diagnosing. The dura-
tion of the disease, clinical information, medication, con-
comitant diseases as well as sociodemographic
information were obtained. The patient satisfaction with
the professional level and attitude of the physician was
assessed using a questionnaire that contained 10 items
and was tested in a pilot study.
The ethical committee of the University of Duisburg-Essen
approved the study. Proportions were expressed as per-
cents. Values of the obtained clinical SI values were com-
pared both between MC- and CU-patients with SPSS 12.0
(SPSS Inc., Chicago, IL, USA). To measure the degree of
correlation between SI, HADS and the satisfaction scores
the Pearson rank correlation test was used. All metric data
are presented as means (± standard deviation). For com-BMC Health Services Research 2009, 9:17 http://www.biomedcentral.com/1472-6963/9/17
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parison of groups the Wilcoxon rank test was used for con-
tinuous variables, the Fisher s exact test for dichotomous
variables and the Chi-square test for ordinal variables. An
alpha-error (p) of less than 5 per cent was considered sig-
nificant.
Results
Patient characteristics
112 consecutive patients were potentially eligible for this
study. 86 questionnaires returned from 5 general practi-
tioners, 3 gastroenterologists and 3 clinics (response rate
77%). Among those 86 patients, 59 patients had CD (19
men, 40 women) and 27 had UC (8 men, 19 women).
The mean age was 40.9 ± 12.1 years. A summary of socio-
demographic characteristics is given in table 1.
26 patients could not be included in the study because of
anxiety for loss of personal integrity, lack of interest or
lack of time. 14 of these patients filled out a short ques-
tionnaire. 9 of them suffered from CD, 5 from UC (6 men,
8 women). The mean age was 41,7 ± 2,3 years.
Time to diagnosis
Time to diagnosis means the duration of the diagnostic
process, calculated from the first visit until the diagnosis
was made. Table 2 gives an overview of the number of
physicians visited and the duration until getting the diag-
nosis. 9% of the patients spent more than 2 years, 6%
more than 3 years and 19% more than 4 years until get-
ting the right diagnosis. Until then, 19% visited more than
5 physicians.
Diagnostic procedures – Examinations during the last 12 
month because of disease before diagnosing and before 
definite diagnosis
Before getting a confirmed diagnosis, 32 patients had no
abdomen-ultrasound. 63% of the CD-patients and 25%
of the UC-patients were examined by colonoscopy. 37%
of the CD-patients and 25% of the UC-patients were
examined by rectoscopy. Both groups did not significantly
differ regarding radiological examinations (x-ray, com-
puted-tomography (CT) or magnetic resonance imaging
(MRI). A summary of all examinations is given in table 3.
During one-year period (12 months) after being diag-
nosed with IBD, 13 patients had more than 3 radiological
examinations. There was no significant difference
between the groups regarding endoscopic examinations,
abdomen-ultrasound or radiological examinations. 21
patients had more than 3 times abdomen-ultrasound. 10
patients had more than 3 colonoscopies during the last 12
months (table 3).
Quality of life, Symptom Intensity
IBD patients had a significantly reduced quality of life
(Physical Component Summary (PCS) and Mental Com-
ponent Summary (MCS)) compared to the summary
scales for the 1998 German normative population [10]:
The overall values in our cohort were 45.1 ± 9.1 for PCS
and 43.6 ± 12.0 for MCS. The overall values in the norma-
tive population were 49.1 for PCS and 50.2 for MCS. The
difference between CD- and UC-patients is statistically
significant (p = 0.01). The differences between CD-
patients as well as UC-patients and the normative popula-
tion are statistically significant, too (p = 0,000). Figure 1
shows the PCS and MCS values for both CD and UC. SI
was significantly higher in tertiary care patients (5.3 ± 5.9)
compared to patients in secondary (3.0 ± 3.5) and pri-
mary care (2.1 ± 2.2). 41 of the 86 patients at that time
suffered from strong quality of life restricting symptoms
and discomfort.
Determinants of patient satisfaction
Over all, 60% of the CD-patients and 70% of the UC-
patients described their treatment as very good or good.
40% of the CD-patients and 30% of the UC-patients
described their treatment as moderate or bad. There differ-
ences between CD and UC were not statistically signifi-
cant. Four most hampering problems were identified:
1. long duration until definite diagnosis (35%)
2. insufficient information for patients (26%)
Table 1: Patient characteristics
Ulcerative colitis Crohn's disease Total
(N = 27) (N = 59) (N = 86)
Age (mean value) 43.2 (10.5) 39.8 (12.7) 40.9 (12.1)
Sex N (%) N (%) N (%)
Female 19 (70) 40 (68) 59 (69)
Male 8 (30) 19 (32) 27 (31)BMC Health Services Research 2009, 9:17 http://www.biomedcentral.com/1472-6963/9/17
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3. an impersonally treatment (21%) and
4. a bad subjective coordination between general practi-
tioner and gastroenterologist respectively general practi-
tioner/gastroenterologist and clinic, which from the
patient's point of view impinges negatively on the whole
treatment (19%). More than a third of all patients (41%)
consulted psychotherapists and non-medical practition-
ers. These patients gave significantly higher satisfaction
ratings (p = 0.01). The time to diagnosis and the number
of doctors visited were significantly correlated with
patient satisfaction (p = 0.01): the longer the time to diag-
nosis the less satisfied the patients. Satisfaction ratings
were not related to severity of disease activity. Figure 2
shows the overall patient satisfaction.
Medication
Information on medication use was available in 84 of 86
cases. 5 patients (4%) were treated with a TNF-alpha-anti-
body. 29% received immunomodulators and 59% were
treated with corticosteroids. 17% received 4 or more dif-
ferent medications, 21% received 3 different medications
and 28% received 1 or 2 types of medication. Table 4 gives
an overview of disease severity and medication category.
Discussion
The aim of the study was to evaluate the current situation
of treatment and to identify variables that influence the
quality of care and patient satisfaction.
In summary, the patients in our study had a significantly
diminished quality of life compared to healthy controls as
assessed by the 1998 German National Health Interview
and Examination Survey [9]. A long duration for getting
the definite diagnosis as well as insufficient information
was ranked among the most urgent problems by the
patients. In spite of being under medical treatment about
half of the patients at that time suffered from quality of
life restricting symptoms and discomfort. The number of
patients who did not get abdominal-ultrasound before
diagnosing is remarkable. UC-patients were less examined
by colonoscopy resp. rectoscopy even though therapy
guidelines suggest endoscopy intervals to provide confi-
dence in the diagnosis [13].
Medical treatment for CD and UC has two main aims: to
achieve or maintain remission. Therefore, treatment is
aimed at controlling the permanent intestinal inflamma-
tion. In this population, as far as it could be ascertained,
Table 2: Number of physicians visited until diagnoses and time until diagnosis
Ulcerative colitis Crohn's disease Total
(N = 27) (N = 59) (N = 86)
Number of physicians visited until diagnosis 1–2 55% 42% 49%
3–4 22% 32% 27%
5–6 7% 14% 11%
more than 7 11% 5% 8%
unknown 4% 5% 5%
n/a 2% 1%
Time until diagnosis same year 67% 38% 53%
1 years 7% 17% 12%
2 years 11% 7% 9%
3 years 4% 7% 6%
more than 4 years 12% 22% 17%
unknown 7% 4%
n/a 2% 1%B
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Table 3: Examinations during the last 12 months because of disease and before definite diagnosis (absolute frequency)
Examinations Diagnosis Total Frequency (because of disease) Frequency (before diagnosing)
At no time 1 – 2 times 3 – 5 times More than 6 times Un-known N/A At no time 1 – 2 times 3 – 5 times More than 6 times Un-known N/A
Abdominal 
ultrasound
CD 59 12 30 13 4 14 30 9 3 2 1
UC 27 10 12 4 1 18 3 2 1 2 1
EGD CD 59 35 18 3 3 29 20 6 1 3
UC 27 21 5 1 22 3 1 1
Colonoscopy CD 59 19 31 8 1 21 30 6 1 1
UC 27 10 14 1 1 1 11 15 1
Rectoscopy CD 59 35 19 1 2 2 28 17 2 3 6 3
UC 27 17 4 3 1 2 14 12 1
X-ray of chest CD 59 35 21 1 2 30 19 3 5 2
UC 27 19 4 1 1 2 19 4 3 1
X-ray of 
stomach
CD 59 39 16 1 1 2 30 19 4 1 5
UC 27 22 3 1 1 19 6 1 1B
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CT of chest CD 59 50 4 2 3 47 4 6 2
UC 27 26 1 26 1
CT of stomach CD 59 42 12 1 2 2 50 4 2 3
UC 27 22 4 1 25 1 1
MRI of chest CD 59 55 1 1 2 55 1 2 1
UC 27 24 1 2 16 1
MRI of stomach CD 59 47 9 1 2 53 4 1 1
UC 27 21 5 1 26 1
Table 3: Examinations during the last 12 months because of disease and before definite diagnosis (absolute frequency) (Continued)BMC Health Services Research 2009, 9:17 http://www.biomedcentral.com/1472-6963/9/17
Page 7 of 10
(page number not for citation purposes)
29 (49%) CD-patients were in remission, 17 (29%) in
moderate und 5 (8%) in severe active disease. Among the
UC-patients, 18 (67%) had a mild, 5 (19%) a moderate
and 1 patient had a severe active disease. Patients with
extensive medication mainly were treated by specialists
and in clinics. It is questionable whether
￿ too few patients were treated with immunomodulators
￿ the treatment with corticosteroids perhaps took too long
￿ a group of UC-patients was not treated with Mesalazine-
derivate and if so, why.
However, a more detailed analysis of the medical therapy
would exit the main focus of the study, but should be
regarded in further investigations of this subject matter.
Reddy et al already showed that IBD-patients did not get
indicated medication and optimal doses but prolonged
steroid therapy [8].
Physical Component Summary (PCS) and Mental Component Summary (MCS) Figure 1
Physical Component Summary (PCS) and Mental Component Summary (MCS). The German National Health 
Interview and Examination Survey included the SF-36-Questionnaire as an instrument for measuring health-related quality of 
life. A description of a German normative population sample is given as a result of the subjective assessment by 6964 survey 
participants aged between 18 and 80 years [10].BMC Health Services Research 2009, 9:17 http://www.biomedcentral.com/1472-6963/9/17
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It has been shown that the subjective view of health is
influenced not only by physical symptoms, but also by the
level of worries and concerns about the disease [14]. The
results of the consensus meeting by the Deutsche Gesells-
chaft für Verdauungs- und Stoffwechselkrankheiten e.V.
(DGVS) describe new evidence-based data on psychoso-
matic treatment of patients with CD and UC [15]. But has
it been put into action? We found that more than a third
of all patients consulted psychotherapists and nonmedi-
cal practitioners. Satisfaction ratings of these patients were
significantly higher. Moreover, patients who sought care
from psychotherapists and non-medical practitioners suf-
fered significantly less from depression. Randomized
studies showed that psychotherapy could be superior to
conventional medical therapy in improving outcomes
such as symptoms intensity. Psychotherapy as an example
is initially expensive but its benefits may increase over
time and finally reduce consultations and health care
costs [15]. However, patients often report that they have
difficulty in getting information about the psychological
consequences of their diseases. Many physicians are not
able to devote as much time to the patient as they want. In
consequence, a lot of patients seek care from psychother-
apists and non-medical practitioners to get personalized
care and to have access to information.
Combining additional treatment options with conven-
tional treatment in a concept of integrated therapy could
better meet patients need and improve outcomes [16].
Diseaserelated self-help organisations play an important
role in the health care system in Germany. In our study
population, IBD-patients who were members of a self-
help group had an increased knowledge about the disease.
However, the results of our study must be interpreted with
some caution, since the limitations of this study have to
be taken into account. For instance the sample is no aver-
age sample, among others due to the design of the study
and therefore does not enable us to generalize e.g. the cor-
relation of time to diagnosis and satisfaction ratings. In
contrast to the planned number of cases, a smaller
number of patients was involved in the study. While it was
intended to include 200 patients with IBD, data from 86
of 112 patients became available. The short recruitment
period turned out to be difficult in high-frequented gas-
troenterology practices. It was not possible to prolong the
survey itself because of the schedule of the overall project.
Overall patient satisfaction Figure 2
Overall patient satisfaction. 60% of the CD-patients and 70% of the UC-patients described their treatment as very good or 
good.BMC Health Services Research 2009, 9:17 http://www.biomedcentral.com/1472-6963/9/17
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But the number of recruited patients is very similar to the
rates observed in other trials in this field [17,18]. Even
though the sample size may limit generalisation of our
data, we assessed all patients who presented at chosen
practices and hospitals during the study period and we
achieved a response rate of 77%. Assessing data from non-
participants to analyse for potential non-responder bias,
we did not observe a statistically significant difference
between patient characteristics. It has to be emphasized,
that primary and secondary care patients as well as tertiary
care patients were involved in this study. Because we did
not only recruit patients in a tertiary care centre, there was
no single sided preselection and patients in different
stages of the disease were included. Because of the cross
sectional design, a firm conclusion about the causal rela-
tion between SI and consultation behaviour cannot be
drawn, but we found at least a statistical association
between quality of care and the investigated outcomes,
that may have public health relevance.
In Germany guidelines for IBD have existed for several
years. We revealed the adherence to guidelines to be a
problem area in the treatment process. This finally affects
the quality of care concerning the physical condition as
well as patient satisfaction and quality of life.
Moreover, a regular problem is the time for physician-
patient-communication and information. Structural defi-
ciencies, due to the health care policy, such as finance,
insurance and politics have a great impact on the time
physicians spend with patients [19].
Conclusion
Our findings support the assumption that maintaining
constant physician-patient-communication improves
patient satisfaction. Cooperation between primary, sec-
ondary and tertiary care was found to have an impact on
patient satisfaction, too. Despite of a well-established
cooperation in the local gastroenterological field, our
results showed improvement options in the treatment of
IBD-patients. In the city of Essen, improvement options
concerning the problems mentioned before have been
discussed jointly. Concrete actions have been developed
and implemented in cooperation with the enlisted prac-
tices and clinics as well as representatives of patient organ-
isations. Therefore the Essener Zirkel project has become
member of the initiative "Gesundes Land Nordrhein-
Westfalen" of the Department of Health of North Rhine-
Westphalia.
Research in this area is fragmented, further investigations
should address the problem of involving larger propor-
tions of IBD patients in primary, secondary and tertiary
care.
Competing interests
The authors declare that they have no competing interests.
Table 4: Disease severity and medication category
Ulcerative colitis Crohn's disease Total
(N = 27) (N = 58) N=(84)
Disease Severity
Mild 67% 49% 55%
Moderate 19% 29% 26%
Severe 4% 8% 7%
unknown 10% 14% 12%
Medication category
Immunosuppressant 19% 34% 29%
Systemic steroids 26% 38% 32%
Topical steroids 22% 31% 27%
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